Treatment of osteolytic, osteoblastic, and mixed bone metastases of solid tumours and osteolytic lesions of multiple myeloma, in conjunction with standard antineoplastic therapy.
Treatment of hypercalcaemia of malignancy (HCM).
Exclusive offer for doctors
Register for a MIMS account and receive free medical publications worth $139 a year.